• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The significance of the hemalexin C1q, RBP, and urinary NAG levels in the diagnosis and prognosis of children with purpura nephritis.血红素结合蛋白C1q、视黄醇结合蛋白及尿N-乙酰-β-D-氨基葡萄糖苷酶水平在紫癜性肾炎患儿诊断及预后中的意义
Am J Transl Res. 2021 Jun 15;13(6):7065-7070. eCollection 2021.
2
Application of urinary N-acetyl-β-D-glucosaminidase combined with serum retinol-binding protein in early detection of diabetic nephropathy.尿N-乙酰-β-D-氨基葡萄糖苷酶联合血清视黄醇结合蛋白在糖尿病肾病早期检测中的应用
World J Diabetes. 2023 Jun 15;14(6):883-891. doi: 10.4239/wjd.v14.i6.883.
3
[Significance of low molecular weight urinary protein for assessment of early renal damage in patients with multiple myeloma].低分子量尿蛋白对评估多发性骨髓瘤患者早期肾损伤的意义
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013 Apr;21(2):410-4. doi: 10.7534/j.issn.1009-2137.2013.02.031.
4
[Clinical study on treatment of childhood Henoch-Schonlein purpura nephritis with colquhounia root tablet].[火把花根片治疗小儿过敏性紫癜性肾炎的临床研究]
Zhongguo Zhong Xi Yi Jie He Za Zhi. 2004 May;24(5):418-21.
5
[Value of blood apoH gene expression and urinary NAG and RBP in early diagnosis of renal function damage in neonates].[血液载脂蛋白H基因表达及尿N-乙酰-β-D-氨基葡萄糖苷酶和视黄醇结合蛋白在新生儿肾功能损害早期诊断中的价值]
Zhongguo Dang Dai Er Ke Za Zhi. 2009 Aug;11(8):649-52.
6
Urinary N-acetyl-beta-D-glucosaminidase (NAG) in lupus nephritis and rheumatoid arthritis.狼疮性肾炎和类风湿关节炎中的尿N-乙酰-β-D-氨基葡萄糖苷酶(NAG)
J Clin Lab Anal. 2005;19(4):172-6. doi: 10.1002/jcla.20073.
7
Netilmicin effect on urinary retinol binding protein (RBP) and N-acetyl-beta-D-glucosaminidase (NAG) in preterm newborns with and without anoxia.奈替米星对有或无缺氧情况的早产新生儿尿视黄醇结合蛋白(RBP)和N-乙酰-β-D-氨基葡萄糖苷酶(NAG)的影响。
J Chemother. 2002 Feb;14(1):76-83. doi: 10.1179/joc.2002.14.1.76.
8
Early tubular proteinuria and the development of nephritis in Henoch-Schönlein purpura.过敏性紫癜早期肾小管蛋白尿与肾炎的发展
Pediatr Nephrol. 2000 Nov;15(1-2):85-9. doi: 10.1007/s004670000403.
9
Urinary excretion of n-acetyl-beta-D-glucosaminidase and retinol binding protein as alternative indicators of nephropathy in patients with type 1 diabetes mellitus.1型糖尿病患者尿中N-乙酰-β-D-氨基葡萄糖苷酶和视黄醇结合蛋白的排泄作为肾病的替代指标
Pediatr Diabetes. 2002 Mar;3(1):37-41. doi: 10.1034/j.1399-5448.2002.30107.x.
10
The dynamics of urinary N-acetyl-β-D-glucosaminidase (NAG), a marker of renal tubular dysfunction, in patients with lupus nephritis undergoing oral prednisone therapy.狼疮肾炎患者口服泼尼松治疗期间尿液 N-乙酰-β-D-氨基葡萄糖苷酶(NAG)的动力学变化,NAG 是肾小管功能障碍的标志物。
Immunopharmacol Immunotoxicol. 2012 Feb;34(1):163-9. doi: 10.3109/08923973.2011.585343. Epub 2011 Jun 9.

本文引用的文献

1
Tubulointerstitial nephritis and uveitis syndrome: Our experience.肾小管间质性肾炎与葡萄膜炎综合征:我们的经验。
Oman J Ophthalmol. 2020 May 28;13(2):89-91. doi: 10.4103/ojo.OJO_56_2016. eCollection 2020 May-Aug.
2
Physician-patient interaction and medication adherence in lupus nephritis.医患互动与狼疮性肾炎患者的药物依从性。
Lupus. 2020 Sep;29(10):1168-1178. doi: 10.1177/0961203320935977. Epub 2020 Jul 5.
3
Population pharmacokinetics of mycophenolic acid in Mexican patients with lupus nephritis.墨西哥狼疮肾炎患者麦考酚酸的群体药代动力学。
Lupus. 2020 Aug;29(9):1067-1077. doi: 10.1177/0961203320931567. Epub 2020 Jun 15.
4
Severe lupus nephritis: an unexpected association with Fabry disease.重症狼疮性肾炎:与法布里病的意外关联。
Lupus. 2020 Jul;29(8):1004-1005. doi: 10.1177/0961203320928396. Epub 2020 Jun 3.
5
Rituximab use as induction therapy for lupus nephritis: a systematic review.利妥昔单抗用于狼疮肾炎诱导治疗:系统评价。
Lupus. 2020 Jul;29(8):892-912. doi: 10.1177/0961203320928412. Epub 2020 Jun 2.
6
Long-term outcomes of lupus nephritis treated with regimens based on cyclophosphamide and mycophenolate mofetil.基于环磷酰胺和霉酚酸酯的方案治疗狼疮肾炎的长期结局。
Lupus. 2020 Jul;29(8):845-853. doi: 10.1177/0961203320926256. Epub 2020 May 21.
7
Interleukin-34 as a marker for subclinical proliferative lupus nephritis.白细胞介素-34作为亚临床增殖性狼疮性肾炎的标志物
Lupus. 2020 May;29(6):607-616. doi: 10.1177/0961203320914976. Epub 2020 Apr 1.
8
Understanding the dynamics of hydroxychloroquine blood levels in lupus nephritis.了解狼疮性肾炎中羟氯喹血药浓度的动态变化。
Lupus. 2020 May;29(6):560-568. doi: 10.1177/0961203320912832. Epub 2020 Mar 19.
9
Choroidal thickness in lupus nephritis.狼疮性肾炎的脉络膜厚度。
Lupus. 2020 Feb;29(2):205-209. doi: 10.1177/0961203319898765. Epub 2020 Jan 10.
10
Patient Outcomes of Henoch-Schönlein Purpura Nephritis According to the New Semiquantitative Classification.根据新的半定量分类,过敏性紫癜肾炎患者的预后。
Fetal Pediatr Pathol. 2020 Oct;39(5):381-389. doi: 10.1080/15513815.2019.1658245. Epub 2019 Sep 6.

血红素结合蛋白C1q、视黄醇结合蛋白及尿N-乙酰-β-D-氨基葡萄糖苷酶水平在紫癜性肾炎患儿诊断及预后中的意义

The significance of the hemalexin C1q, RBP, and urinary NAG levels in the diagnosis and prognosis of children with purpura nephritis.

作者信息

Zhang Huiwu, Li Xiuli, Xu Haiping, Ran Fang, Zhao Guoxia

机构信息

Department III of Pediatric, Cangzhou Central Hospital Cangzhou, China.

Department II of Nephrology, Cangzhou Central Hospital Cangzhou, China.

出版信息

Am J Transl Res. 2021 Jun 15;13(6):7065-7070. eCollection 2021.

PMID:34306465
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8290666/
Abstract

PURPOSE

To investigate the significance of the hemalexin C1q, retinal-binding-protein (RBP), and urinary N-acety1-β-D-glucosaminidase (NAG) levels in the diagnosis and prognosis of children with purpura nephritis.

METHODS

A total of 130 children with purpura nephritis admitted to our hospital from January 2017 to December 2019 were recruited as the study cohort, including 43 children with purpura nephritis as the observation group, 51 children with purpura nephritis as the control group, and 36 healthy children undergoing physical examinations at the same time period as the healthy group. The basic data of the three groups of children were compared, and the hemalexin C1q, RBP, and urinary NAG levels were observed. The children were divided into a good prognosis group and a poor prognosis group according to the observation group's follow-up data. The significance of the hemalexin C1q, RBP, and urinary NAG levels for the diagnosis and prognosis of children with purpura nephritis was investigated by comparing the hemalexin C1q, RBP, and urinary NAG levels in these two groups.

RESULTS

The hemalexin C1q, RBP, and urinary NAG levels in the observation group, the control group, and the healthy group were significantly reduced, and the differences were statistically significant (P < 0.05). The hemalexin C1q, RBP, and urinary NAG levels of the children in the good prognosis group were significantly lower than they were in the poor prognosis group (P < 0.05).

CONCLUSION

The hemalexin C1q, RBP, and urinary NAG levels in the diagnosis and prognosis of children with purpura nephritis have a definite value and can be used as effective predictors for the prognosis of children with purpura nephritis.

摘要

目的

探讨血抑素C1q、视网膜结合蛋白(RBP)及尿N-乙酰-β-D-氨基葡萄糖苷酶(NAG)水平在紫癜性肾炎患儿诊断及预后中的意义。

方法

选取2017年1月至2019年12月我院收治的130例紫癜性肾炎患儿作为研究队列,其中43例紫癜性肾炎患儿为观察组,51例紫癜性肾炎患儿为对照组,同期36例健康体检儿童为健康组。比较三组儿童的基本资料,观察血抑素C1q、RBP及尿NAG水平。根据观察组随访资料将患儿分为预后良好组和预后不良组。通过比较两组患儿血抑素C1q、RBP及尿NAG水平,探讨其在紫癜性肾炎患儿诊断及预后中的意义。

结果

观察组、对照组及健康组血抑素C1q、RBP及尿NAG水平均显著降低,差异有统计学意义(P<0.05)。预后良好组患儿血抑素C1q、RBP及尿NAG水平显著低于预后不良组(P<0.05)。

结论

血抑素C1q、RBP及尿NAG水平在紫癜性肾炎患儿诊断及预后中具有一定价值,可作为紫癜性肾炎患儿预后的有效预测指标。